BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Accord BioPharma’s IMULDOSA® (ustekinumab-srlf) Now Preferred Under Cigna Healthcare Commercial Plans

  April 20, 2026

   · 

  9 min read
• Press Releases

  JAMP Pharma Group Strengthens Its Immunology Biosimilars Portfolio with PrUpgolyv™, a Golimumab Biosimilar that has Receive its Notice of Compliance by Health Canada.

  April 20, 2026

   · 

  5 min read
• Press Releases

  Adcendo ApS Provides Updates on Pipeline Progress and Recent Achievements for Its First- and Best-in-Class Antibody-Drug Conjugates

  April 20, 2026

   · 

  5 min read
• Press Releases

  Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update

  April 20, 2026

   · 

  4 min read
• Press Releases

  Ampersand Biomedicines Presents Preclinical Data on AMP-220, a Gut-Targeted IL-22 AND-Body™ Therapeutic, at AAI 2026

  April 20, 2026

   · 

  3 min read
• Press Releases

  Deck Bio Presents Preclinical Data on DBXO-1, a Multi-pMHC Targeted T Cell Engager, at AACR 2026

  April 20, 2026

   · 

  3 min read
• Press Releases

  Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

  April 20, 2026

   · 

  5 min read
• Press Releases

  BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure

  April 20, 2026

   · 

  3 min read
• Press Releases

  Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor

  April 20, 2026

   · 

  3 min read
• Press Releases

  Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

  April 20, 2026

   · 

  3 min read